drugset / Trial / NCT00293631
Study of Lornoxicam or Ketorolac or Placebo for Post-Operative Pain After Bunionectomy
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for management of post-operative pain in patients who have surgical removal of a bunion on the lower extremity. One-fourth of patients in this study will receive a single dose of intravenous ketorolac for management of pain and one-fourth of patients in this study will receive a single dose of an intravenous placebo.
Timeline
- Start
- 2005-11
- Primary completion
- 2006-03
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac | Other / unclassified | 30 mg | Intravenous |
| Subject | Lornoxicam | Small molecule | 8 mg | Intravenous |
| Subject | Lornoxicam | Small molecule | 16 mg | Intravenous |
Indications
No indication recorded.